WHO vaccine-preventable diseases: monitoring system. 2014 global summary

Last updated 15-Jul-2014 (Data received as of 8-Jul-2014)
Next overall update Fall 2014
EPI mother and child logo         
Select a country

Development status: Least developed GNI / capita (US$): 5201 Infant (under 12 months) mortality rate: 812
GDP / capita (US$): 1'2421 Child (under 5 years) mortality rate: 1292

Population data in thousands3

  2013  2012  2011  2010  2009  2000  1990  1980 
Total population 1'704  1'664  1'624  1'587  1'551  1'273  1'017  818 
Births 64  63  62  61  61  53  46  38 
Surviving infants 58  57  56  55  55  47  40  33 
Pop. less than 5 years 270  265  261  256  251  215  179  142 
Pop. less than 15 years 707  693  679  665  653  554  451  351 
Female 15-49 years 407  397  386  376  366  299  232  187 

Number of reported case

(Click for retrospective incidence data for Guinea-Bissau)
Diphtheria
Japanese encephalitis
Measles 26  259  1'332 
Mumps
Pertussis 1'512  1'250 
Polio*
Rubella 23 
Rubella (CRS)
Tetanus (neonatal) 45 
Tetanus (total) 45  221 
Yellow fever
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV);"
"it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Guinea-Bissau)
Vaccine year result method % card seen                                                
BCG 2009  94  MICS   83  95  95  99  93  83  90 
DTP1 2009  94  MICS   83  100  90  99*  99*  84 
DTP3 2009  81  MICS   83  96  90  89  86  82  61 
HepB_BD         
HepB3          96  90  89  86  82 
Hib3          96  90  89  86  82 
JapEnc         
MCV 2009  69  MICS   83  89  90  78  78  79  53 
MCV2         
PCV1         
PCV3         
Pol3 2009  79  MICS   83  96  90  90  83  89  60 
Rota1         
Rota_last         
Rubella1         
TT2plus 2009  58  MICS   83  38  45  32  70  34  31 
PAB         
VAD1          94  79 
YFV 2009  57  MICS   83  73  90  78  78  80 
  ° indicates that more than 1 survey occurred that year

  Next update: July 2015

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Guinea-Bissau)
BCG 94  94  94  94  94  77  90 
DTP1 92  92  92  92  92  73  82 
DTP3 80  80  80  80  80  49  61 
HepB3 76  76  76  76  76 
HepB_BD
Hib3 76  76  76  76  76 
MCV 69  69  69  69  69  71  53 
MCV2
PAB 80  80  80  78  94  49  40 
PCV3
Pol3 78  78  78  78  78  52  60 
Rota_last
YFV 61  61  61  61  61 

Number of districts in the country 11  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
81 
   
/
|
|
\
Greater or equal to 90% 73
From 80 to 89% 18
From 50 to 79% 9
Less than 50% 0
Proportion of districts
not reporting DTP3 coverage
0
 

Immunization Schedule (2013 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DTwPHibHepB 6,10,14 weeks; Yes
Measles 9 months; Yes
OPV birth; 6, 10, 14 weeks; Yes
TT 1st contact; +1, +6 months; +1, +1 year; Yes
YF 9 months; Yes

Immunizaton indicators

Indicator Expected answer 2013  2012  2011  2010  2009  2008  2007 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
What years does the MYP cover? number 2013 - 2017  2013 - 2017  2010-2014  2010-2014  2010-2014    2005-2009 
Nº of districts with microplans that include activities to raise immunization coverage number 11  11    11  11  10 

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR No  No  No  No       

System performance

Total Nº districts in country number 11  11  11  11  11  11  11 
Nº districts with DTP3 coverage >=80% number 10  10  10 
% of districts with DTP3 coverage >=80% From 0 to 100% 91  91  64  91  55 
Nº districts with measles (MCV1) coverage >=95% number  
% of districts with MCV1 coverage >=95% From 0 to 100% 55  27  27  27   

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND No  No  No  No       
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  No  Yes  No  No  No  No 

Finance

Estimated percentage of routine vaccines funded by Government From 0 to 100%      

Sources

 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2013, data for 2012
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.